
中东和非洲过敏反应治疗市场预测至 2028 年 - COVID-19 影响和按药物类型(肾上腺素、抗组胺药、类固醇、β 激动剂等)、给药途径(口服、肠胃外等)、过敏类型进行的区域分析(食物过敏、药物、昆虫叮咬等)和分销渠道(医院药房、零售等)
No. of Pages: 143 | Report Code: TIPRE00023952 | Category: Life Sciences
No. of Pages: 143 | Report Code: TIPRE00023952 | Category: Life Sciences
过敏反应是一种过敏反应,可进一步导致称为过敏性休克的致命疾病。当患者的身体对异物产生反应并产生大量组胺从而引发炎症反应时,就会发生过敏反应。这是一种严重的、危及生命的过敏反应,其症状包括吞咽和呼吸困难、皮肤瘙痒和血压降低。
因此,过敏反应发生率的上升预计将对过敏反应产生巨大的需求未来几年,预计这将进一步推动过敏反应治疗市场。
中东国家的社会经济状况也受到了 COVID-19 大流行的广泛影响。然而,各国对新冠肺炎 (COVID-19) 大流行做出了明智的反应,以避免感染传播。与其他地区类似,实行了封锁和社会疏远,这削弱了这些趋势,阻碍了人们获得工作、正常收入、付款、展会、学校和医疗保健。因此,预计这些国家已经遭受了巨大损失,并且仍在努力挽回损失。由于经济欠发达,大多数国家都依赖医疗器械供应商。此外,COVID-19在非洲和喀麦隆、埃及、阿尔及利亚、摩洛哥、南非、多哥、尼日利亚、塞内加尔和突尼斯等其他低收入国家的传播存在高度不确定性。由于 COVID-19 在非洲广泛爆发,导致医疗服务中断。然而,由于该地区对该地区与病毒感染相关的哮喘和过敏性疾病的治疗认识不断增强,此次大流行中的过敏反应治疗市场正在增长。
< strong>主要细分市场
就药物类型而言,肾上腺素细分市场在2020年中东和非洲过敏反应治疗市场中占据最大份额。从给药途径来看,2020年中东和非洲过敏反应治疗市场中,注射给药细分市场占据最大份额;从过敏类型来看,食物过敏细分市场在中东和非洲过敏反应治疗市场中占据最大份额2020年,从分销渠道来看,零售药店在2020年过敏反应治疗市场中占有较大的市场份额。
准备本过敏反应治疗市场报告时提到的一些主要一手和二手来源中东和非洲的网站包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Amneal Pharmaceuticals Inc.、Mylan NV、Abbott、Pfizer Inc.、Glaxosmithkline Plc.、Merck and Co., Inc.、Teva Pharmaceutical Industries Ltd. 和 ALK-ABELLó。
< p>按药物类型 p>
p>
按给药途径
按过敏类型
按分销渠道
按国家/地区
Strategic insights for Middle East and Africa Anaphylaxis Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 52.2 Million |
Market Size by 2028 | US$ 87.1 Million |
Global CAGR (2021 - 2028) | 7.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 药物类型
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa Anaphylaxis Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Anaphylaxis Treatment Market is valued at US$ 52.2 Million in 2021, it is projected to reach US$ 87.1 Million by 2028.
As per our report Middle East and Africa Anaphylaxis Treatment Market, the market size is valued at US$ 52.2 Million in 2021, projecting it to reach US$ 87.1 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.
The Middle East and Africa Anaphylaxis Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Anaphylaxis Treatment Market report:
The Middle East and Africa Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.